Virtual - Zoom
login details provided upon registration
This event starts on at
Topic: Healthcare Investing in 2021
Join us as we reflect on private equity investment in the healthcare industry during 2020 and shift towards sectors to watch in 2021. We’ll provide an overview of trends/factors impacting 2020 that have created opportunities in 2021. Our panel will discuss how interruptions encountered during the pandemic helped formulate innovative investment thesis’ and opportunities which will continue to play out over the next 12 months and beyond. Our experts will also discuss alternative deal structures considered to address financial uncertainties caused by the pandemic and how those terms may evolve as we optimistically move forward. Lastly, we will discuss healthcare sectors anticipated to receive the most interest from private equity over the next 6-12 months.
By Invitation Only
Opus Connect is a membership-based organization.
If you have any queries, please contact firstname.lastname@example.org
*Opus Connect adheres to a strict no cancellations, no refunds, no application of registration fees to future events policy.
Qualified substitutions are accepted. To send a substitute, please notify email@example.com
**Opus Connect reserves the right to refuse entry to prospective attendees
Jerry is a Principal in Plante Moran’s Transaction Advisory Services practice. He specializes in providing merger and acquisition due diligence services to private equity sponsors, and organizations who invest across healthcare. Jerry has 20 years of experience providing accounting, assurance, and consulting services to small and large privately-held entities, and entities with public reporting requirements. Jerry has served clients who invest in a variety of sectors in healthcare including physician practices, physical therapy, addiction/behavioral health, autism, adult day services, home health and hospice, RCM, SAAS, and hospitals and health systems. Jerry is a member of the Association for Corporate Growth (ACG) and frequent presenter on the M&A topic to various organizations.
Bobby Guy believes that the innovation and disruption in the US healthcare market presents the greatest investment opportunity in healthcare for the last half century. He is a healthcare deal lawyer with Polsinelli, and he spends his time focused on growing, buying and selling healthcare companies. In the last four years his team has bought and sold more than 500 healthcare businesses across the US, from post-acute to behavioral health, senior housing to healthcare tech. He is the host of The 10 Minute HealthBizCast, focused on “Exploring Ways To Make Healthcare Better”, hails from Nashville, Tennessee, and was named the Corporate LiveWire 2020 Securities Lawyer of the Year.
Chris Cathcart is a Managing Partner and currently serves on the Management and Investment Committees of The Halifax Group. Chris joined Halifax in 2007 and leads business development for the firm. He is responsible for origination, evaluation and recommendation of investment opportunities and management of the firm’s network of investment sources. Chris has eighteen years of experience leading and advising small businesses including political organizations and entrepreneurial medical technology businesses.
Chris received an MBA from The Kellogg School of Management at Northwestern University with a concentration in finance, accounting and entrepreneurship and graduated cum laude from Wake Forest University.
Chris is a long suffering Wake Forest sports fan. When not lamenting the current on-field performance of his beloved Demon Deacons, he serves on the board of deacons at his church, enjoys spending time with his young family and endures distance running.
Larry established the Firm’s Los Angeles office and has led the
Firm’s transaction sourcing effort in the western U.S. since joining Clearview in 2005. Previously,
Larry was a Principal with Triton Pacific Capital Partners, LLC, a private equity group based in Los
Angeles, where he led the firm’s transaction sourcing efforts. He brings an extensive background
in origination, structuring, financing and execution of middle-market transactions to Clearview.
Previously, Larry was with Mille Capital and The Shattan Group, LLC, both New York-based middlemarket
investment banking firms where he originated and executed institutional private equity
financings and M&A engagements for clients. Larry has an MBA from Columbia Business School
and received his undergraduate degree from The Wharton School of the University of Pennsylvania.
Mr. Thompson is a Partner at Enhanced. He focuses on sourcing, evaluating, executing and managing niche investments in the healthcare with experience in pharma, technology, pharmacy and reimbursed services. Prior to Enhanced, Mr. Thompson served as a Director at Riverside Partners, a private equity firm with a focus on healthcare and technology. Before joining Riverside Partners, Mr. Thompson worked at CVS Caremark in the corporate development and strategy role, helping lead work in a wide range of sectors including pharmacy, senior living, disease management, HCIT, wellness, and medical clinics. He was also a consultant at Monitor Group where he managed growth oriented and M&A projects in a variety of sectors. He holds a Bachelor of Science from Georgetown University.